Aptamer Sciences Inc.
- Biotech or pharma, therapeutic R&D
Aptamer Sciences Inc., a clinical-stage biopharmaceutical company listed on KOSDAQ in South Korea, is a global leader in the field of aptamer technology. The company has built a fully integrated aptamer-based platform for targeted therapies, known as Aptamer Drug Conjugate (ApDC®), and is primarily focused on developing oncology pipelines.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}